Edoardo D'Angelo (E D'Angelo)

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 12

Top Venues

Cancers

Gels (Basel, Switzerland)

International journal of cancer

Cancer gene therapy

University of Padua

University of Padova (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Padua May 15 2019

Italy

Research fellow :: Department of SUrgery, Oncology and Gastroenterology

Istituto di Ricerca Pediatrica - Fondazione Città della Speranza Jan 11 2016 - May 14 2019

Italy

short-term contract :: Nano-inspired biomedicine laboratory

Euroclone Life Science Division

Italy

External Researcher (Fellow)

Education History

University of Padova - Apr 05 2018

Italy

PHD :: Department of Surgery, Oncology and Gastroenterology

University of Verona

Italy

MSC :: Biotechnology

Publications

Eleonora Zanrè, Eva Dalla Valle, Edoardo D'Angelo, Francesca Sensi, Marco Agostini, Elisa Cimetta
Recent Advancements in Hydrogel Biomedical Research in Italy. Gels (Basel, Switzerland) 10 (4) (2024)
Eleonora Zanrè, Eva Dalla Valle, Edoardo D'Angelo, Francesca Sensi, Marco Agostini, Elisa Cimetta
Recent Advancements in Hydrogel Biomedical Research in Italy. Gels (Basel, Switzerland) 10 (4) (2024)
Eleonora Zanrè, Eva Dalla Valle, Edoardo D'Angelo, Francesca Sensi, Marco Agostini, Elisa Cimetta
Recent Advancements in Hydrogel Biomedical Research in Italy. Gels (Basel, Switzerland) 10 (4) (2024)
Edoardo D'Angelo, Chiara Pastrello, Andrea Biccari, Asia Marangio, Francesca Sensi, Sara Crotti, Matteo Fassan, Igor Jurisica, Salvatore Pucciarelli, Marco Agostini
An integrated multi-omics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-Fluorouracil. International journal of cancer (2023)
Edoardo D'Angelo, Chiara Pastrello, Andrea Biccari, Asia Marangio, Francesca Sensi, Sara Crotti, Matteo Fassan, Igor Jurisica, Salvatore Pucciarelli, Marco Agostini
An integrated multiomics analysis of rectal cancer patients identified POU2F3 as a putative druggable target and entinostat as a cytotoxic enhancer of 5-fluorouracil. International journal of cancer (2023)
Asia Marangio, Andrea Biccari, Edoardo D'Angelo, Francesca Sensi, Gaya Spolverato, Salvatore Pucciarelli, Marco Agostini
The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation? Cancers 14 (23) (2022)
Asia Marangio, Andrea Biccari, Edoardo D'Angelo, Francesca Sensi, Gaya Spolverato, Salvatore Pucciarelli, Marco Agostini
The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation? Cancers 14 (23) (2022)
Asia Marangio, Andrea Biccari, Edoardo D'Angelo, Francesca Sensi, Gaya Spolverato, Salvatore Pucciarelli, Marco Agostini
The Study of the Extracellular Matrix in Chronic Inflammation: A Way to Prevent Cancer Initiation? Cancers 14 (23) (2022)
Silvia Barbon, Andrea Biccari, Elena Stocco, Giovanni Capovilla, Edoardo D'Angelo, Martina Todesco, Deborah Sandrin, Andrea Bagno, Filippo Romanato, Veronica Macchi, Raffaele De Caro, Marco Agostini, Stefano Merigliano, Michele Valmasoni, Andrea Porzionato
Bio-Engineered Scaffolds Derived from Decellularized Human Esophagus for Functional Organ Reconstruction. Cells 11 (19) (2022)
Erica Gentilin, Edoardo D'Angelo, Marco Agostini, Laura Astolfi
Decellularized normal and cancer tissues as tools for cancer research. Cancer gene therapy (2021)
Sara Coletta, Silvia Lonardi, Francesca Sensi, Edoardo D'Angelo, Angelo Paolo Dei Tos, Salvatore Pucciarelli, Arianna Valzelli, Andrea Biccari, William Vermi, Chiara Della Bella, Annica Barizza, Mario Milco D'Elios, Marina de Bernard, Marco Agostini, Gaia Codolo
Tumor Cells and the Extracellular Matrix Dictate the Pro-Tumoral Profile of Macrophages in CRC. Cancers 13 (20) (2021)
Edoardo D'Angelo, Carlo Zanon, Francesca Sensi, Maura Digito, Massimo Rugge, Matteo Fassan, Marco Scarpa, Salvatore Pucciarelli, Donato Nitti, Marco Agostini
miR-194 as predictive biomarker of responsiveness to neoadjuvant chemoradiotherapy in patients with locally advanced rectal adenocarcinoma. Journal of clinical pathology 71 (4) (2017)

Edoardo D'Angelo.css-eqlu8i{font-size:small;padding-left:4px;} (E D'Angelo)

Publication Activity (10 Years)

Top Topics

Top Venues

Edoardo D'Angelo (E D'Angelo)